KCM
TNDM icon

KRS Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

KRS Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-400
Closed -$60K – 337
2021
Q4 		$60K Buy
+400
New +$54K 0.05% 217

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

KRS Capital Management's TNDM Position: Q1 2022 in Review

KRS Capital Management sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 400 shares — an estimated $60K sold.

KRS Capital Management first reported a position in TNDM in Q4 2021 and held it in 1 quarter. The position peaked at $60K in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • KRS Capital Management reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • KRS Capital Management sold 400 Tandem Diabetes Care shares in Q1 2022, an estimated $60K.
  • KRS Capital Management first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 1 quarter.
  • KRS Capital Management's Tandem Diabetes Care position peaked at $60K in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on KRS Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.